Patents by Inventor Stuart Alexander Cook

Stuart Alexander Cook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of fibrosis with interleukin-11 receptor alpha antibody
    Patent number: 10899832
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: January 26, 2021
    Assignees: Singapore Health Services PTE LTD, National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 receptor alpha antibody
    Patent number: 10894827
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: January 19, 2021
    Assignees: Singapore Health Services PTE LTD, National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 receptor alpha antibody
    Patent number: 10894826
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: January 19, 2021
    Assignees: Singapore Health Services PTE LTD, National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 antibody
    Patent number: 10894825
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: January 19, 2021
    Assignees: Singapore Health Services PTE LTD, National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 receptor alpha antibody
    Patent number: 10889642
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: January 12, 2021
    Assignees: Singapore Health Services PTE LTD, National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 antibody
    Patent number: 10870696
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: December 22, 2020
    Assignees: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 antibody
    Patent number: 10870697
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: December 22, 2020
    Assignees: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 antibody
    Patent number: 10865241
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: December 15, 2020
    Assignees: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 antibody
    Patent number: 10865239
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: December 15, 2020
    Assignees: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with interleukin-11 antibody
    Patent number: 10865240
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: December 15, 2020
    Assignees: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • TREATMENT AND PREVENTION OF METABOLIC DISEASES
    Publication number: 20200384083
    Abstract: Methods of treating and preventing metabolic disease through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.
    Type: Application
    Filed: May 1, 2020
    Publication date: December 10, 2020
    Applicants: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer, Brijesh Kumar, Anissa Widjaja
  • IL-11RA ANTIBODIES
    Publication number: 20200377605
    Abstract: Provided are antigen-binding molecules capable of binding to IL-11R?, and methods of medical treatment and prophylaxis using the same.
    Type: Application
    Filed: June 13, 2019
    Publication date: December 3, 2020
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • Treatment of fibrosis with IL-11 receptor alpha antibody
    Patent number: 10822405
    Abstract: Aspects of the disclosure relate to the treatment, prevention or alleviation of conditions such as fibrosis in a subject. In some embodiments, the treatment, prevention or alleviation of fibrosis in a subject through the administration of an agent capable of inhibiting the action of Interleukin 11 (IL-11) is disclosed.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: November 3, 2020
    Assignees: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • TREATMENT OF KIDNEY INJURY
    Publication number: 20200270340
    Abstract: Methods of treating and preventing kidney injury through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.
    Type: Application
    Filed: February 21, 2020
    Publication date: August 27, 2020
    Applicants: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer, Anissa Anindya Widjaja
  • TREATMENT OF HEPATOTOXICITY
    Publication number: 20200262910
    Abstract: Methods of treating and preventing hepatotoxicity through inhibiting interleukin 11 (IL-11)-mediated signalling are disclosed, as well as agents for use in such methods.
    Type: Application
    Filed: January 21, 2020
    Publication date: August 20, 2020
    Applicants: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer, Anissa Widjaja
  • IL-11RA ANTIBODIES
    Publication number: 20200207847
    Abstract: IL-11Ra antibodies are disclosed. Also disclosed are compositions comprising the IL-11Ra antibodies, and methods using the IL-11Ra antibodies.
    Type: Application
    Filed: December 23, 2019
    Publication date: July 2, 2020
    Applicants: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • IL-11 ANTIBODIES
    Publication number: 20200199218
    Abstract: IL-11 antibodies are disclosed. Also disclosed are compositions comprising the IL-11 antibodies, and methods using the IL-11 antibodies.
    Type: Application
    Filed: December 23, 2019
    Publication date: June 25, 2020
    Applicants: Singapore Health Services PTE LTD., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • IL-11 ANTIBODIES
    Publication number: 20200031918
    Abstract: Provided are antigen-binding molecules capable of binding to IL-11, and methods of medical treatment and prophylaxis using the same.
    Type: Application
    Filed: June 13, 2019
    Publication date: January 30, 2020
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • IL-11RA ANTIBODIES
    Publication number: 20190389957
    Abstract: Provided are antigen-binding molecules capable of binding to IL-11R?, and methods of medical treatment and prophylaxis using the same.
    Type: Application
    Filed: June 13, 2019
    Publication date: December 26, 2019
    Inventors: Stuart Alexander Cook, Sebastian Schaefer
  • DECOY CYTOKINE RECEPTOR
    Publication number: 20190345226
    Abstract: An IL-11 binding receptor capable of binding to IL-11 and inhibiting IL-11 mediated signalling is disclosed. Also disclosed are compositions comprising the IL-11 binding receptor and methods using the IL-11 binding receptor.
    Type: Application
    Filed: December 15, 2017
    Publication date: November 14, 2019
    Applicants: Singapore Health Services Pte. Ltd., National University of Singapore
    Inventors: Stuart Alexander Cook, Sebastian Schaefer